Zotepine
SIGMA/Z0877
Synonym: 2-
CAS Number: 26615-21-4
Empirical Formula (Hill Notation): C18H18ClNOS
Molecular Weight: 331.86
MDL Number: MFCD00868143
Linear Formula: C18H18ClNOS
Product Type: Chemical
assay | >98% (HPLC) |
color | white to off-white |
form | powder |
InChI | 1S/C18H18ClNOS/c1-20(2)9- |
InChI key | HDOZVRUNCMBHFH-UHFFFAOYSA |
originator | Astellas |
Quality Level | 100 ![]() |
SMILES string | CN(C)CCOC1=Cc2ccccc2Sc3cc |
solubility | DMSO: ≥20 mg/mL |
storage temp. | room temp |
Application: | Zotepine has been used as an anti-psychotic agent: • in biophysical studies with serotonin 2A receptor (5-HT2AR) • to study its effects on the inhibition of human organic cation transporter 1 (hOCT1) • to study its protective effects on the human embryonic kidney (HEK cells) |
Biochem/physiol Actions: | Zotepine acts as an antagonist of dopamine D1, D2, and serotonin (5-HT2A/2C) receptors, and noradrenaline transporter |
Biochem/physiol Actions: | Zotepine is an atypical antipsychotic. |
Features and Benefits: | This compound is featured on the Dopamine Receptors ![]() ![]() |
Features and Benefits: | This compound was developed by Astellas ![]() ![]() |
Other Notes: | Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. Z0877.pdf ![]() ![]() |
Packaging: | 10, 50 mg in glass bottle |
Symbol | ![]() ![]() |
Signal word | Warning |
Hazard statements | H302 - H400 |
Precautionary statements | P273 |
Hazard Codes | T |
Risk Statements | 25-50/53 |
Safety Statements | 45-60-61 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | >98% (HPLC) |
Storage Temp. | room temp |
UNSPSC | 12352200 |